Han, Kai
Nam, Jutaek
Xu, Jin
Sun, Xiaoqi
Huang, Xuehui
Animasahun, Olamide http://orcid.org/0000-0002-4032-3619
Achreja, Abhinav
Jeon, Jin Heon http://orcid.org/0000-0002-8427-8514
Pursley, Benjamin
Kamada, Nobuhiko
Chen, Grace Y.
Nagrath, Deepak http://orcid.org/0000-0002-8999-2282
Moon, James J. http://orcid.org/0000-0003-2238-2372
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070, R01AI127070)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB022563)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK125087)
Article History
Received: 18 September 2020
Accepted: 14 May 2021
First Online: 24 June 2021
Competing interests
: A patent application (WO/2021/061789) for in situ modulation of the gut microbiome has been filed, with J.J.M., K.H., J.X. and X. H. as inventors.